Clinical Trials Liability Coverage
Clinical Trials Liability Insurance protects pharmaceutical companies, biotechnology firms, research organizations, healthcare institutions, and clinical trial sponsors against the financial and legal exposures arising from clinical research and human trial activities.
Coverage is designed to support financial stability and operational continuity when participants allege bodily injury, adverse reactions, or harm arising from clinical trials, investigational products, or research procedures.
Coverage typically responds to claims involving participant injury, protocol deviations, trial administration errors, informed consent issues, adverse events, or third-party liability arising from clinical research and testing activities conducted across domestic and international jurisdictions.
Coverage may also include protection for legal defense costs, regulatory investigations, ethics review requirements, cross-border research exposures, and liabilities associated with contract research organizations (CROs), investigators, and multinational trial operations.
For multinational organizations, Clinical Trials Liability coverage may be coordinated through a Controlled Master Program (CMP), such as the WMB Global Risks Global Master Program, with locally admitted policies where required to support coordinated liability protection, regulatory compliance, and consistent coverage standards across jurisdictions.
Clinical Trials Liability Insurance is designed to help organizations manage complex research exposures, protect participants and stakeholders, and maintain continuity throughout clinical development and research operations.